Homepage
Category:
Globe Newswire
Posted Date:
February 24, 2026
Free ROI Calculator for Identity Verification: A New Tool to Help Small and Medium Businesses Make Informed Decisions
Regula Forensics
February 24, 2026
Bolt Biotherapeutics to Participate in Upcoming March Conferences
Bolt Biotherapeutics, Inc.
February 24, 2026
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
MaxCyte, Inc
February 24, 2026
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant
Artiva Biotherapeutics, Inc.
February 24, 2026
Aerospike Wins Most Innovative Data Platform in SiliconANGLE Media’s Tech Innovation CUBEd Awards
Aerospike Inc
February 24, 2026
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
Candel Therapeutics
February 24, 2026
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference
Annexon Biosciences
February 24, 2026
AmpliTech Group Announces Expiration of Previously Listed Warrants (NASDAQ: AMPGW)
AmpliTech Group, Inc.
February 24, 2026
Moomoo and W!se Award $10,000 to Queens Gateway to Health Sciences Secondary School as Part of Student Stock Showdown Challenge
Moomoo
February 24, 2026
Holzer & Holzer, LLC Reminds RGNX Investors of the April 14, 2026 Lead Plaintiff Deadline in the REGENXBIO Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds TCPC Investors of the April 6, 2026 Lead Plaintiff Deadline in the BlackRock TCP Capital Corp. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds FRMI Investors of the March 6, 2026 Lead Plaintiff Deadline in the Fermi Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds PLUG Investors of the April 3, 2026 Lead Plaintiff Deadline in the Plug Power Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds BRBR Investors of the March 23, 2026 Lead Plaintiff Deadline in the BellRing Brands, Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds RARE Investors of the April 6, 2026 Lead Plaintiff Deadline in the Ultragenyx Pharmaceutical Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds PSFE Investors of the April 7, 2026 Lead Plaintiff Deadline in the Paysafe Limited Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds VRNS Investors of the March 9, 2026 Lead Plaintiff Deadline in the Varonis Systems, Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds BBWI Investors of the March 13, 2026 Lead Plaintiff Deadline in the Bath & Body Works, Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds POM Investors of the April 6, 2026 Lead Plaintiff Deadline in the POMDOCTOR LIMITED Securities Class Action
Holzer & Holzer
February 24, 2026
NÖK Therapeutics to Participate in BIO Investment & Growth Summit in Miami
NÖK Therapeutics, Inc.
February 24, 2026
Holzer & Holzer, LLC Reminds QURE Investors of the April 13, 2026 Lead Plaintiff Deadline in the uniQure N.V. Securities Class Action
Holzer & Holzer
February 24, 2026
Vera Therapeutics to Participate at Upcoming Investor Conferences
Vera Therapeutics
February 24, 2026
Holzer & Holzer, LLC Reminds BYND Investors of the March 24, 2026 Lead Plaintiff Deadline in the Beyond Meat, Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds KD Investors of the April 13, 2026 Lead Plaintiff Deadline in the Kyndryl Holdings, Inc. Securities Class Action
Holzer & Holzer
February 24, 2026
Holzer & Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action
Holzer & Holzer
February 24, 2026
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026
Absci Corporation
February 24, 2026
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
IN8bio, Inc
February 24, 2026
Montreal Comiccon Returns July 3-5, 2026 at Palais des congrès with Star-Studded Lineup and Entertaining Programming!
Montreal Comiccon
February 24, 2026
ORYZON Receives European Medicines Agency Approval to Initiate a Phase II Study of iadademstat in Essential Thrombocythemia
Oryzon Genomics, S.A.
February 24, 2026
IBN Announces Latest Episode of The TechMediaWire Podcast featuring David BenDavid, CEO of Rail Vision Ltd.
InvestorBrandNetwork (IBN)
February 24, 2026
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
Legend Biotech USA Inc.
February 24, 2026
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
Cabaletta Bio
February 24, 2026
Septerna to Present at TD Cowen 46th Annual Health Care Conference
Septerna, Inc.
February 24, 2026
Gentex Announces First Quarter 2026 Cash Dividend
Gentex Corporation
February 24, 2026
UK Atomic Energy Authority to Support Pulsar Fusion with Neutron Shielding Modelling for Sunbird Fusion Propulsion Programme
Pulsar Fusion
February 24, 2026
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
Krystal Biotech, Inc.
February 24, 2026
AssetMark Announces 2026 Community Inspiration Award Winners at Gold Forum
AssetMark, Inc.
February 24, 2026
Ophirex to Supply Marimastat Drug Substance to Liverpool School of Tropical Medicine for Novel Snakebite Treatment Research
Ophirex
February 24, 2026
Lumanity Launches EMULaiTOR™, an AI-Powered Synthetic Persona Platform Transforming Stakeholder Engagement in Life Sciences
Lumanity
February 24, 2026
Alector to Participate in the TD Cowen 46th Annual Health Care Conference
Alector, Inc.
February 24, 2026
BriteCore to Host Joint Webinar With Ivans Insurance on Scaling Agent Connectivity Without Operational Bottlenecks
BriteCore
February 24, 2026
Nu-Tek BioSciences to Highlight Animal-Origin-Free Peptones, Supply Chain Strength at DCAT Week 2026
Nu-Tek Biosciences, LLC
February 24, 2026
Collabtech Group Announces Acquisition of MediaCentric
Collabtech Group
February 24, 2026
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
Helus Pharma
February 24, 2026
ADW Capital Management Sends Letter to Compass Diversified’s Board Calling for an Immediate Strategic Review Process and Orderly Liquidation of the Company
ADW Capital Management, LLC
February 24, 2026
Promatix Biosciences Presents Positive Preclinical Data with First-in-Class PBS293 EGFR×EphA2 Cis-Bispecific ADC Demonstrating Enhanced Tumour Selectivity
Promatix Biosciences, Ltd.
February 24, 2026
ZenaTech Wins the Morrissey Goodale 2026 Most Prolific and Proficient Acquirer Award for Growing its Drone as a Service Network
ZenaTech Inc.
February 24, 2026
Stallion Uranium Announces Completion of Ground Gravity Extension Survey over Coyote Corridor
Stallion Uranium Corp.
February 24, 2026
Porosome Therapeutics Announces New Porosome-Targeted Medicines Developed Using AI
Porosome Therapeutics, Inc.
February 24, 2026
Rio Silver Inc. Invites Investors to Meet Management at PDAC 2026, the World’s Premier Mining Convention
Rio Silver, Inc.
February 24, 2026
Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company
Olenox Industries Inc.
February 24, 2026
Purpose Investments Inc. Announces Final February 2026 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
Purpose Investments Inc.
February 24, 2026
Allied Announces Renewal Of Normal Course Issuer Bid
Allied Properties REIT
February 24, 2026
Stardust Power Joins Cornerstone Consortium to Support U.S. Critical Minerals and Industrial Base Resilience
Stardust Power Inc.
February 24, 2026
Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency
Rekor Systems
February 24, 2026
Apogee Therapeutics to Participate in Upcoming March Conferences
Apogee Therapeutics
February 24, 2026
Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases
Alveus Therapeutics Inc
February 24, 2026
Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
Jeito Capital
February 24, 2026
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals International, Plc
February 24, 2026
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
Radiopharm Theranostics
February 24, 2026
Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
Mainz BioMed NV
February 24, 2026
GDS Announces Adjournments of Extraordinary General Meeting and Additional Shareholders Meetings to be Reconvened on March 10, 2026
GDS Holdings Limited
February 24, 2026
INVESTOR ALERT: Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead the Class Action Lawsuit – RGRD Law
Robbins Geller Rudman & Dowd LLP
February 24, 2026
AMD and Meta Announce Expanded Strategic Partnership to Deploy 6 Gigawatts of AMD GPUs
Advanced Micro Devices, Inc.
February 24, 2026
Xometry Announces CEO Succession Plan
Xometry, Inc.
February 24, 2026
Q2 Metals Discovers High Grade Zone with 170.2 Metre Intercept of 1.99% Li₂O, Including 40.1 m of 2.89% Li₂O at the Cisco Lithium Project
Q2 Metals Corp
February 24, 2026
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Transcenta
February 24, 2026
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
Treace Medical Concepts, Inc.
February 24, 2026
Lahontan Drills High Grade Oxide Gold from the Surface at West Santa Fe: 37m Grading 3.11 g/t Au Eq Including 11m Grading 5.75 g/t Au Eq
Lahontan Gold
February 24, 2026
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Cullinan Therapeutics, Inc.
February 24, 2026
OROCO COMMENCES PHASE 2 DRILLING
Oroco Resource Corp.
February 24, 2026
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
Shoals Technologies Group
February 24, 2026
Garrett Motion Announces Participation at the Bank of America Global Automotive Summit
Garrett Motion Inc.
February 24, 2026
Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator
Shoals Technologies Group
February 24, 2026
First Watch Restaurant Group, Inc. Reports 2025 Financial Results and Provides Outlook for 2026
First Watch Restaurant Group, Inc.
February 24, 2026
Canada’s Rental Market Stabilizes in 2026 — But Supply Risks Are Building
liv.rent
February 24, 2026
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
YieldMax
February 24, 2026
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
Invivyd
February 24, 2026
The Canadian Queer Chamber of Commerce Launches The FAM Program to Support 2SLGBTQI+ businesses and Entrepreneurs Nationwide
Canadian Queer Chamber of Commerce
February 24, 2026
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
Emerging Growth
February 24, 2026
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Larimar Therapeutics
February 24, 2026
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
Monte Rosa Therapeutics, Inc.
February 24, 2026
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Sotera Health Services, LLC
February 24, 2026
New Survey Data Reveals What Canadian Mortgage Brokers Want Most from Private Lenders… and Most Aren’t Getting It
Perch Capital
February 24, 2026
First Watch Restaurant Group, Inc. Announces Retirement of Chief Financial Officer Mel Hope and Transition Plan
First Watch Restaurant Group, Inc.
February 24, 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Fulcrum Therapeutics, Inc.
February 24, 2026
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Fulcrum Therapeutics, Inc.
February 24, 2026
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
Atea Pharmaceuticals, Inc.
February 24, 2026
OTC Markets Group Welcomes GR Silver Mining Ltd. to OTCQX
OTC Markets
February 24, 2026
OTC Markets Group Welcomes Dryden Gold Corp. to OTCQX
OTC Markets
February 24, 2026
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
Aquestive Therapeutics, Inc.
February 24, 2026
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
Beam Therapeutics
February 24, 2026
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
Beam Therapeutics
February 24, 2026
OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX
OTC Markets
February 24, 2026
Autolus Therapeutics to Participate in Upcoming Investor Conferences
Autolus Therapeutics plc
February 24, 2026
Ongwe Minerals Secures Additional Licenses, Significantly Increases Its Omatjete Project Area and Identifies Prospective Parallel Fault Zone
Ongwe Minerals Inc.
February 24, 2026
Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
Dianthus Therapeutics, Inc.
February 24, 2026
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
Kymera Therapeutics, Inc.
February 24, 2026
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Foghorn Therapeutics, Inc.
February 24, 2026
Amendment of the Liquidity Agreement with Kepler Cheuvreux
Theon International PLC
February 24, 2026
Prev
1
…
310
311
312
313
314
…
400
Next
